|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Green JA, Kirwan JM, Tierney JF, et al:
Survival and recurrence after concomitant chemotherapy and
radiotherapy for cancer of the uterine cervix: a systematic review
and meta-analysis. Lancet. 358:781–786. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Martin-Loeches M, Ortí RM, Cazorla E,
Asins E and Lixiona J: Multivariate analysis of the morphometric
characteristics of tumours as prognostic factors in the survival of
patients with uterine cervix cancer treated with radical surgery.
Eur J Obstet Gynecol Reprod Biol. 105:170–176. 2002. View Article : Google Scholar
|
|
4
|
Gasinska A, Urbanski K, Adamczyk A,
Pudelek J, Lind BK and Brahme A: Prognostic significance of
intratumour microvessel density and haemoglobin level in carcinoma
of the uterine cervix. Acta Oncol. 41:437–443. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Goudy G, Stoeckle E, Thomas L, et al:
Prognostic impact of tumour volume and lymph node involvement in
intermediate stage T1b1 to T2b cancer of the uterine cervix. Bull
Cancer. 96:685–694. 2009.(In French).
|
|
6
|
Grigiene R, Valuckas KP, Aleknavicius E,
Kurtinaitis J and Letautiene SR: The value of prognostic factors
for uterine cervical cancer patients treated with irradiation
alone. BMC Cancer. 7:2342007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Su ZZ, Kang DC, Chen Y, et al:
Identification and cloning of human astrocyte genes displaying
elevated expression after infection with HIV-1 or exposure to HIV-1
envelope glycoprotein by rapid subtraction hybridization, RaSH.
Oncogene. 21:3592–3602. 2002. View Article : Google Scholar
|
|
8
|
Brown DM and Ruoslahti E: Metadherin, a
cell surface protein in breast tumors that mediates lung
metastasis. Cancer Cell. 5:365–374. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sarkar D, Emdad L, Lee SG, Yoo BK, Su ZZ
and Fisher PB: Astrocyte elevated gene-1: far more than just a gene
regulated in astrocytes. Cancer Res. 69:8529–8535. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liao WT, Guo L, Zhong Y, Wu YH, Li J and
Song B: Astrocyte elevated gene-1 (AEG-1) is a marker for
aggressive salivary gland carcinoma. J Transl Med. 9:2052011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu L, Wu J, Ying Z, et al: Astrocyte
elevated gene-1 upregulates matrix metalloproteinase-9 and induces
human glioma invasion. Cancer Res. 70:3750–3759. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yoo BK, Emdad L, Su ZZ, et al: Astrocyte
elevated gene-1 regulates hepatocellular carcinoma development and
progression. J Clin Invest. 119:465–477. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu C, Chen K, Zheng H, et al:
Overexpression of astrocyte elevated gene-1 (AEG-1) is associated
with esophageal squamous cell carcinoma (ESCC) progression and
pathogenesis. Carcinogenesis. 30:894–901. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li J, Zhang N, Song LB, et al: Astrocyte
elevated gene-1 is a novel prognostic marker for breast cancer
progression and overall patient survival. Clin Cancer Res.
14:3319–3326. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kikuno N, Shiina H, Urakami S, et al:
Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer
progression through upregulation of FOXO3a activity. Oncogene.
26:7647–7655. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu J-B, Wu H, He Y-L, Zhang C-H, Zhang
L-J, Cai S-R and Zhan W-H: Astrocyte-elevated gene-1 overexpression
is associated with poor prognosis in gastric cancer. Med Oncol.
28:455–462. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen W, Ke Z, Shi H, Yang S and Wang L:
Overexpression of AEG-1 in renal cell carcinoma and its correlation
with tumor nuclear grade and progression. Neoplasma. 57:522–529.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Song LB, Li W, Zhang HZ, et al:
Over-expression of AEG-1 significantly associates with tumour
aggressiveness and poor prognosis in human non-small cell lung
cancer. J Pathol. 219:317–326. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ash SC, Yang DQ and Britt DE: LYRIC/AEG-1
overexpression modulates BCCIPa protein levels in prostate tumor
cells. Biochem Biophys Res Commun. 371:333–338. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Thirkettle HJ, Mills IG, Whitaker HC and
Neal DE: Nuclear LYRIC/AEG-1 interacts with PLZF and relieves
PLZF-mediated repression. Oncogene. 28:3663–3670. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li J, Yang L, Song L, et al: Astrocyte
elevated gene-1 is a proliferation promoter in breast cancer via
suppressing transcriptional factor FOXO1. Oncogene. 28:3188–3196.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Santarpia M, Magri I, Sanchez-Ronco M, et
al: mRNA expression levels and genetic status of genes involved in
the EGFR and NF-κB pathways in metastatic non-small-cell lung
cancer patients. J Transl Med. 9:1632011.PubMed/NCBI
|
|
23
|
Li C, Li R, Song H, et al: Significance of
AEG-1 expression in correlation with VEGF, microvessel density and
clinicopathological characteristics in triple-negative breast
cancer. J Surg Oncol. 103:184–192. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hu GH, Chong RA, Yang QF, et al: MTDH
activation by 8q22 genomic gain promotes chemoresistance and
metastasis of poor-prognosis breast cancer. Cancer Cell. 15:9–20.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu H, Song X, Liu C, Li X, Wei L and Sun
R: Knockdown of astrocyte elevated gene-1 inhibits proliferation
and enhancing chemo-sensitivity to cisplatin or doxorubicin in
neuroblastoma cells. J Exp Clin Cancer Res. 28:192009. View Article : Google Scholar
|
|
26
|
Yoo BK, Gredler R, Vozhilla N, et al:
Identification of genes conferring resistance to 5-fluorouracil.
Proc Natl Acad Sci USA. 106:12938–12943. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lee SG, Su ZZ, Emdad L, Sarkar D and
Fisher PB: Astrocyte elevated gene-1 (AEG-1) is a target gene of
oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc.
Proc Natl Acad Sci USA. 103:17390–17395. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee SG, Su ZZ, Emdad L, Sarkar D, Franke
TF and Fisher PB: Astrocyte elevated gene-1 activates cell survival
pathways through PI3K-Akt signaling. Oncogene. 27:1114–1121. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sarkar D, Park ES, Emdad L, Lee SG, Su ZZ
and Fisher PB: Molecular basis of nuclear factor-kappaB activation
by astrocyte elevated gene-1. Cancer Res. 68:1478–1484. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Emdad L, Sarkar D, Su ZZ, et al:
Activation of the nuclear factor-kappaB pathway by astrocyte
elevated gene-1: implications for tumor progression and metastasis.
Cancer Res. 66:1509–1516. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xi W, Rui W, Fang L, Ke D, Ping G and
Zhang H-Z: Expression of stathmin/op18 as a significant prognostic
factor for cervical carcinoma patients. J Cancer Res Clin Oncol.
135:837–846. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li B, Zhang LJ, Zhang ZL, et al:
Synergistic tumor growth inhibition effect of prostate-specific
antigen-activated fusion peptide BSD352 for prostate cancer
therapy. Anticancer Drugs. 22:213–222. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Long M, Yin G, Liu L, et al:
Adenovirus-mediated Aurora A shRNA driven by stathmin promoter
suppressed tumor growth and enhanced paclitaxel chemotherapy
sensitivity in human breast carcinoma cells. Cancer Gene Ther.
19:271–281. 2012. View Article : Google Scholar
|
|
34
|
Moore MA, Attasara P, Khuhaprema T, et al:
Cancer epidemiology in mainland South-East Asia - past, present and
future. Asian Pac J Cancer Prev. 11(Suppl 2): 67–80.
2010.PubMed/NCBI
|
|
35
|
Folkman J: Tumor angiogenesis. Adv Cancer
Res. 43:175–203. 1985. View Article : Google Scholar
|
